$800M+ in B2B pipeline · 6 active sectors · 2024–2026
Zishaan Rauf connects vetted operators with the capital, deal flow, and talent they need — precisely when it matters.
- Commercial Production
- Wealth
- M&A
- AI
- Healthcare
- Recruitment
- →New agency accounts and fresh funding rounds triggering commercial shoots
- →FDA remediation windows recently opened this quarter
- →OSHA penalty maximums reset to record highs in early 2026
- →Business owners hitting retirement age with no succession plan
Sourced from FDA regulatory filings, OSHA penalty schedules, Gallup/McKinsey succession research, and agency & funding announcements.
- 5 qualified intros in 28 daysCommercial production companies → brands & agencies
- 6 qualified intros in 46 daysHNW business owners seeking a successor → wealth advisory firms
- $180K added in 60 daysExecutive candidates → companies hiring for leadership roles
Selected work across $800M+ transaction environments. 2024–2026.
- Thesis 01 · May 2026 On Post-Production Risk Window → On commercial production — the shoot is the easy part. Budgets and timelines actually break in post-production review cycles.
- Thesis 02 · June 2026 The Remediation Runway → The FDA letter isn't the crisis — it's proof the crisis already happened. The real work starts after.
- Thesis 03 · July 2026 Trust and Timing in Wealth Advisory → In wealth advisory, referrals aren't a lead source — they're the entire trust mechanism. Advisors don't pitch; they inherit credibility.
- Timing and Readiness in B2B MarketsComing soon
- Why Reputation Outperforms the Track RecordComing soon
- Deal Flow as a Trust Network, Not a PipelineComing soon